| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/30/2010 | CA2755983A1 Compounds and methods for modulating an immune response |
| 09/29/2010 | EP2233561A1 Method for amplification of hematopoietic stem cell using heterocyclic compound |
| 09/29/2010 | EP2233486A1 Azaindoles |
| 09/29/2010 | EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation. |
| 09/29/2010 | EP2233473A1 3,5-di(aryl or heteroaryl)isoxazoles and 1,2,4-oxadiazoles as S1P1 receptor agonists, immunosuppresssive and anti-inflammatory agents |
| 09/29/2010 | EP2233149A1 Combination of BLYS inhibition and anti-CD20 agents for treatment of autoimmune disease |
| 09/29/2010 | EP2233141A1 Ppharmaceutical compositions coprising polymorphic forms of dehydroepiandrosterone |
| 09/29/2010 | EP2231708A1 Remedies for pemphigus containing anti fas ligand antobodies |
| 09/29/2010 | EP2231654A1 Novel 2-substituted thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 09/29/2010 | EP2231652A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 09/29/2010 | EP2231595A1 Phenyl acetic acid derivatives as inflammation modulators |
| 09/29/2010 | EP2231190A1 Particulate drug carriers as desensitizing agents |
| 09/29/2010 | EP2231189A1 Drug delivery system for administration of poorly water soluble pharmaceutically active substances |
| 09/29/2010 | EP2231172A1 Immunomodulating compositions and uses therefor |
| 09/29/2010 | EP2231156A1 Methods for increasing white blood cells |
| 09/29/2010 | EP2231145A2 Use of glycosylceramides for enhancing the immune response to antigens |
| 09/29/2010 | EP1729803B1 Therapeutic use of anti-cs1 antibodies |
| 09/29/2010 | EP1534695B1 Tyrosine kinase inhibitors |
| 09/29/2010 | EP1476120B1 Treatment methods using anti-cd22 antibodies |
| 09/29/2010 | EP1450847B1 APO2 ligand/ TRAIL formulations and uses thereof |
| 09/29/2010 | EP1446136B1 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 09/29/2010 | EP1223956B1 Supernatant from mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 09/29/2010 | CN1927403B Medicine for promoting pigling growth and improving pigling immunity and preparing method thereof |
| 09/29/2010 | CN1674868B Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
| 09/29/2010 | CN101849014A Chimeric PUFA polyketide synthase systems and uses thereof |
| 09/29/2010 | CN101848999A Anti-CD20 monoclonal antibodies |
| 09/29/2010 | CN101848926A Peptide capable of binding to immunoglobulin |
| 09/29/2010 | CN101848730A Capsid proteins and uses therefore |
| 09/29/2010 | CN101848725A 组合物 The composition |
| 09/29/2010 | CN101845442A Method for preparing human interleukin 28A by silkworm bioreactor and pharmaceutical application thereof |
| 09/29/2010 | CN101845385A Health-care wine and preparation method thereof |
| 09/29/2010 | CN101843897A Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders |
| 09/29/2010 | CN101843896A Recombinant human interferon alpha 2b injection with high concentration and low filling quantity |
| 09/29/2010 | CN101843895A Cytokine receptor ZCYTOR17 multimers |
| 09/29/2010 | CN101843838A Health-care medicated wine and preparation method thereof |
| 09/29/2010 | CN101843718A Chinese medicament for treating lupus erythematosus |
| 09/29/2010 | CN101843705A Chinese medicament for treating lupus erythematosus |
| 09/29/2010 | CN101843692A Chinese medicament for treating lupus erythematosus |
| 09/29/2010 | CN101843675A Chinese medicament for treating allergic rhinitis and acute/chronic rhinitis, and preparation process thereof |
| 09/29/2010 | CN101843630A Composite containing iridoid compound and application thereof |
| 09/29/2010 | CN101843629A New application of icariin and epimedium flavone containing icariin |
| 09/29/2010 | CN101843625A Compound ofloxacin injection for livestock and preparation method thereof |
| 09/29/2010 | CN101843618A Application of berberine and derivatives thereof in preparation of indole amine 2, 3-dioxygenase inhibitor |
| 09/29/2010 | CN101843616A Composition of fexofenadine hydrochloride and microcrystalline cellulose and preparation method thereof |
| 09/29/2010 | CN101843580A Preparation method of pidotimod injection preparation |
| 09/29/2010 | CN101843362A Eucommia-clerodendrum bungei cigarette and production method thereof |
| 09/29/2010 | CN101524190B Disease preventing and curing medicinal mouth-muffle and medicinal composition |
| 09/29/2010 | CN101321539B Novel combination of anticholinergics, glucocorticoid, Beta2-agonist, PDE 4 inhibitors and antileukotrienes for the treatment of inflammatory disease |
| 09/29/2010 | CN101259177B Medicaments for treating chronic bronchitis and confecting method thereof |
| 09/29/2010 | CN101250236B Tuckahoe dextran phosphate esterified derivative as well as preparation and use thereof |
| 09/29/2010 | CN101249131B Gynostemma pentaphylla effective ingredient extract |
| 09/29/2010 | CN101244163B Tableland yak blood capsule and preparation thereof |
| 09/29/2010 | CN101108190B Application of cryptotanshinone in preparation of medicine preventing and controlling autoimmune disease |
| 09/29/2010 | CN101061106B Potentiators of glutamate receptors |
| 09/29/2010 | CN101045073B Method for preparing extractive of liuyueqing and its application |
| 09/28/2010 | USRE41783 Pyrrolo[2,3-D]pyrimidine compounds |
| 09/28/2010 | US7803944 Viral polymerase inhibitors |
| 09/28/2010 | US7803939 N2,N4-bis(4-ethoxyphenyl)-5-fluoro-2,4-pyrimidinediamine; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 09/28/2010 | US7803840 Use of certain dialkyl fumarates for the preparation of pharmaceutical preparations for use in transplantation medicine or for the therapy of autoimmune diseases and said compositions in the form of micro-tablets or pellets; dimethyl fumarate |
| 09/28/2010 | US7803823 having proinflammatory cytokine production inhibiting properties, in particular tumor necrosis factor-alpha (TNF-alpha) and/or interleukin-12 (IL-12) inhibiting properties, used for the prevention or the treatment of inflammatory and/or autoimmune diseases |
| 09/28/2010 | US7803805 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 09/28/2010 | US7803776 Combined use of enzyme inhibitors and of pharmaceutical compositions thereof |
| 09/28/2010 | US7803766 administering gastrin/(cholecystokinin (CCK) receptor ligand and a factor for complementing gastrin for islet neogenesis therapy; sustained release; for expanding a functional beta cell mass of pancreatic islet transplants; reduces amount of stem cells necessary for treatment; long-acting action |
| 09/28/2010 | US7803749 Prevent signal transduction passageways; kinase inhibitor; modulate immunology response |
| 09/28/2010 | US7803618 nucleic acid encoding an anti-EpCAM protein; binds human epithelial cell adhesion molecule; immunoglobulin light chain region modified to reduce immunogenicity; diagnosis, prognosis and treatment of cancer |
| 09/28/2010 | US7803615 Death domain containing receptor 5 |
| 09/28/2010 | US7803602 Method for overexpression of zwitterionic polysaccharides |
| 09/28/2010 | US7803361 Decreasing solid tumor size in a cancer patient by administering an interleukin-2 mutant with reduced vasopermeability activity compared to a wildtype form, and being Arg38Trp, wherein said wildtype form is human IL-2 mutant and the IL-2 mutant is not linked to an antibody. |
| 09/28/2010 | CA2493765C Benzothiazole derivatives having beta-2-adrenoreceptor agonist activity |
| 09/28/2010 | CA2459482C Novel glycolipid and medicine for autoimmune disease containing the same as active ingredient |
| 09/28/2010 | CA2386417C Phenyl- and pyridyl-tetrahydropyridines having tnf-inhibiting activity |
| 09/28/2010 | CA2380298C Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof |
| 09/28/2010 | CA2376304C Amide substituted imidazoquinolines |
| 09/23/2010 | WO2010107404A1 Stable pharmaceutical combinations |
| 09/23/2010 | WO2010106988A1 Amide derivative |
| 09/23/2010 | WO2010106812A1 Pharmaceutical formulation containing improved antibody molecules |
| 09/23/2010 | WO2010106366A1 Fk506 and fk520 analogues and their pharmaceutical uses |
| 09/23/2010 | WO2010106016A1 Pyrimidine derivatives used as itk inhibitors |
| 09/23/2010 | WO2010105347A1 Vaccination methods |
| 09/23/2010 | WO2010105298A1 Peptidase inhibitor 16 (pi16) as a biomarker for regulatory t (treg) cells and uses thereof |
| 09/23/2010 | WO2010059401A3 Compounds that expand hematopoietic stem cells |
| 09/23/2010 | WO2010033425A3 Nutritional support to prevent or moderate bone marrow paralysis or neutropenia during anti-cancer treatment |
| 09/23/2010 | WO2010033424A3 Nutritional support of the immune system during anti-cancer treatment |
| 09/23/2010 | WO2009131702A9 Antibodies against fcrn and use thereof |
| 09/23/2010 | US20100240873 Ligand (act-4-l) to a receptor on the surface of activated cd4+ tcells |
| 09/23/2010 | US20100240758 External preparation for percutaneous administration containing nonsteroidal anti-inflammatory analgesic |
| 09/23/2010 | US20100240739 Widespread gene delivery to motor neurons using peripheral injection of aav vectors |
| 09/23/2010 | US20100240732 Aptamer-targeted sirna to prevent attenuation or suppression of a t cell function |
| 09/23/2010 | US20100240717 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 09/23/2010 | US20100240704 Method of modulating stress-activated protein kinase system |
| 09/23/2010 | US20100240686 Chemical compounds |
| 09/23/2010 | US20100240680 Purine derivatives as a2a agonists |
| 09/23/2010 | US20100240677 Compounds as PDE IV and TNF Inhibitors |
| 09/23/2010 | US20100240671 Substituted heterocyclic compounds |
| 09/23/2010 | US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application |
| 09/23/2010 | US20100240657 Chemical compounds |
| 09/23/2010 | US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto |
| 09/23/2010 | US20100240651 Water-soluble thalidomide derivatives |
| 09/23/2010 | US20100240650 Substituted pyrrolines as kinase inhibitors |
| 09/23/2010 | US20100240646 Pyrrolo-triazine aniline compounds useful as kinase inhibitors |